Alumis Inc.

ALMS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022
Assets
Cash & Equivalents $89.7M $169.5M $46.0M $27.0M
Accounts Receivable
Inventory
Total Current Assets $318.2M $306.2M $53.4M
Property, Plant & Equipment $18.2M $21.0M $22.4M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $411.9M $341.0M $89.6M
Liabilities
Accounts Payable $10.1M $9.6M $1.1M
Total Current Liabilities $73.3M $50.9M $20.9M
Long-Term Debt
Total Liabilities $110.6M $80.9M $53.5M
Stockholders' Equity
Retained Earnings $-901.9M $-658.6M $-364.3M
Total Stockholders' Equity $301.3M $260.1M $-339.3M $-195.2M